Maine ordered by judge to expand Medicaid

Fifty-nine percent of Maine voters approved a ballot referendum last year to expand Medicaid eligibility in the state. After Republican Gov. Paul LePage repeatedly refused to implement it, a judge ruled Monday LePage's administration has to obey voters’ wishes and submit its expansion plan to CMS.

Maine Superior Court Justice Michaela Murphy issued a 13-page ruling rejecting the argument that the Maine Department of Health and Human Services couldn’t implement a law that hasn’t been funded by state lawmakers and citing the department’s “complete failure to act” on the requirement to submit an expansion plan to federal regulators.

“The court is not persuaded that the executive branch is excused from clear statutory obligations by the legislature’s failure to follow through with legislative obligations—as defined by the executive branch,” Murphy wrote. “The commissioner has not cited to any authority suggesting that an agency can be considered to have substantially complied with a directory statute by taking no action at all.”

Under the ruling, Maine’s HHS now has until June 11 to submit a state plan amendment to CMS.

The lawsuit was filed after LePage’s administration had missed an April 3 deadline to submit its expansion plan. A spokesperson for LePage said the governor is reviewing the decision, but one of the plaintiffs, Maine Equal Justice Partners, declared victory after the ruling was issued.

“The governor cannot ignore the law,” Robyn Merrill, executive director for MEJP, said in a statement. “Maine voters did not make a request at the ballot, they passed a law, and laws are not optional. Today’s ruling is good news for more than 70,000 Mainers who the law says can sign up for healthcare on July 2.”

Maine was the first state to have Medicaid expansion approved directly by voters. Utah will have a similar referendum on its ballot in November. Two other states, Idaho and Nebraska, also have active efforts for ballot initiatives this year but the measures haven’t yet been certified.  

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.